Minimally invasive vs. traditional heart valve surgery
Part of Digestive system, Heart & circulation clinical trials.
This trial compares two types of heart valve surgery: one through a small cut on the right side of the chest (minimally invasive) and one through a cut down the middle of the chest (traditional). It looks at how well patients recover right after surgery to see if one approach is safer or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for surgery to replace or repair your mitral or aortic heart valve.
- Your surgery is planned in advance (not an emergency) and you have not had heart surgery before.
- You are not having any other heart procedures at the same time, like bypass surgery or fixing more than one valve.
- Your heart's pumping strength is not severely reduced (ejection fraction is 30% or higher).
- You do not have severe high blood pressure in your lungs (pulmonary hypertension).
- You do not have an active infection or sepsis at the time of surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This trial tests a minimally invasive procedure to replace a narrowed heart valve in emergency situations, such as cardiac arrest or severe heart failure. It aims to help people who are too sick for standard treatments and need immediate care.
This study is testing less invasive (smaller cut) surgery options for people with aortic heart valve problems. The goal is to see if these minimally invasive approaches can safely and effectively treat your condition with a quicker recovery.
This trial compares two ways to treat a failing aortic valve that was replaced with a tissue valve during surgery: another surgical replacement or a less invasive catheter-based valve-in-valve procedure. It is for people with low to intermediate surgical risk who are between 18 and 75 years old.
This study compares doing aortic valve replacement sooner versus waiting, in people with moderate aortic valve narrowing plus at least moderate leakage in the mitral valve. It aims to see which timing improves heart symptoms and outcomes while keeping treatment safe.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.